Literature DB >> 30853625

Annexin A2 interacting with ELMO1 regulates HCC chemotaxis and metastasis.

Hongyan Li1, Yecheng Wang2, Yinying Lu3, Fei Li4.   

Abstract

AIMS: SDF-1α induced chemotaxis plays an important role in hepatocellular carcinoma metastasis. CXCR4 stimulated by SDF-1α/CXCL12 triggers heterotrimeric G proteins activation, which regulate migration and chemotaxis of hepatocellular carcinoma cells. The pathways linking the chemokine GPCR/Gi signaling to actin polymerization for migration of cancer cells are not known.
MATERIALS AND METHODS: Through would healing assay, chemotaxis assay, F-actin polymerization assay, confocal assay, immunohistochemical assay, protein identification and coimmunoprecipitation assay, we detected the role and mechanisms of Annexin A2 in hepatocellular carcinoma. KEY
FINDINGS: In the present study, we firstly investigated the role of Annexin A2 in HepG2 cell chemotaxis and metastasis. Immunohistochemical analysis showed that Annexin A2 was highly expressed in hepatocellular carcinoma tissues. Its expression was closely associated with lymph node and distant metastasis. Knockdown Annexin A2 impaired cancer cell chemotaxis. Co-immunoprecipitation results showed an interaction between Annexin A2 and ELMO1. CXCL12 triggers an ELMO1-dependent membrane translocation of Annexin A2. SIGNIFICANCE: Taken together, our results indicated an important role of Annexin A2 in hepatocellular carcinoma tissues metastasis and revealed a novel molecular mechanism of its activation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Annexin A2; Chemotaxis; ELMO1; Hepatocellular carcinoma; Metastasis

Mesh:

Substances:

Year:  2019        PMID: 30853625     DOI: 10.1016/j.lfs.2019.03.003

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  Role of ELMO1 in inflammation and cancer-clinical implications.

Authors:  Stefania Tocci; Stella-Rita Ibeawuchi; Soumita Das; Ibrahim M Sayed
Journal:  Cell Oncol (Dordr)       Date:  2022-06-06       Impact factor: 7.051

2.  Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer.

Authors:  Yi Shen; Wei Xiong; Qi Gu; Qin Zhang; Jia Yue; Changsong Liu; Duan Wang
Journal:  Front Med (Lausanne)       Date:  2021-05-24

Review 3.  Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment.

Authors:  Li-Wei Qiu; Yi-Fei Liu; Xiao-Qing Cao; Yan Wang; Xiao-Hong Cui; Xian Ye; Shuo-Wen Huang; Hong-Jun Xie; Hai-Jian Zhang
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

4.  Long noncoding RNA cytoskeleton regulator RNA promotes cell invasion and metastasis by titrating miR-613 to regulate ANXA2 in nasopharyngeal carcinoma.

Authors:  Wei Chen; Mingyu Du; Xinyu Hu; Hongxia Ma; Erbao Zhang; Tingting Wang; Li Yin; Xia He; Zhibin Hu
Journal:  Cancer Med       Date:  2019-12-20       Impact factor: 4.452

5.  TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy.

Authors:  Huan-Tian Zhang; Qingzhong Zeng; Baomeng Wu; Junlei Lu; Kui-Leung Tong; Jiebin Lin; Qiu-Yu Liu; Lipei Xu; Jie Yang; Xiaohui Liu; Wanting Liu; Yun-Fang Zhang; Qionghua Lian; Langxia Liu; Xuejuan Gao
Journal:  Cell Death Dis       Date:  2021-01-06       Impact factor: 8.469

6.  Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma.

Authors:  Fang Wang; Peter Breslin S J; Wei Qiu
Journal:  Liver Res       Date:  2021-06-23

7.  C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 7(CXCR7) regulates epithelial-mesenchymal transition process and promotes the metastasis of esophageal cancer by activating signal transducer and activator of transcription 3 (STAT3) pathway.

Authors:  Jing Guo; Chang-Yong Tong; Jian-Guang Shi; Xin-Jian Li
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 8.  Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy.

Authors:  Lucia Cerrito; Maria Elena Ainora; Carolina Mosoni; Raffaele Borriello; Antonio Gasbarrini; Maria Assunta Zocco
Journal:  Cancers (Basel)       Date:  2022-09-24       Impact factor: 6.575

Review 9.  Epigenetic changes in fibroblasts drive cancer metabolism and differentiation.

Authors:  Rajeev Mishra; Subhash Haldar; Surabhi Suchanti; Neil A Bhowmick
Journal:  Endocr Relat Cancer       Date:  2019-12       Impact factor: 5.678

10.  ELMO2 association with Gαi2 regulates pancreatic cancer cell chemotaxis and metastasis.

Authors:  Yecheng Wang; Hongyan Li; Fei Li
Journal:  PeerJ       Date:  2020-04-06       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.